172 related articles for article (PubMed ID: 38615023)
1. Hit discovery of potential CDK8 inhibitors and analysis of amino acid mutations for cancer therapy through computer-aided drug discovery.
Aghahasani R; Shiri F; Kamaladiny H; Haddadi F; Pirhadi S
BMC Chem; 2024 Apr; 18(1):73. PubMed ID: 38615023
[TBL] [Abstract][Full Text] [Related]
2. All-atomic molecular dynamic studies of human CDK8: insight into the A-loop, point mutations and binding with its partner CycC.
Xu W; Amire-Brahimi B; Xie XJ; Huang L; Ji JY
Comput Biol Chem; 2014 Aug; 51():1-11. PubMed ID: 24754906
[TBL] [Abstract][Full Text] [Related]
3. In Search of Novel CDK8 Inhibitors by Virtual Screening.
Kumarasiri M; Teo T; Yu M; Philip S; Basnet SK; Albrecht H; Sykes MJ; Wang P; Wang S
J Chem Inf Model; 2017 Mar; 57(3):413-416. PubMed ID: 28191946
[TBL] [Abstract][Full Text] [Related]
4. An ensemble machine learning model generates a focused screening library for the identification of CDK8 inhibitors.
Lin TE; Yen D; HuangFu WC; Wu YW; Hsu JY; Yen SC; Sung TY; Hsieh JH; Pan SL; Yang CR; Huang WJ; Hsu KC
Protein Sci; 2024 Jun; 33(6):e5007. PubMed ID: 38723187
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening.
Wang T; Yang Z; Zhang Y; Yan W; Wang F; He L; Zhou Y; Chen L
Eur J Med Chem; 2017 Mar; 129():275-286. PubMed ID: 28231524
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics Strategy.
James N; Ramanathan K
Cell Biochem Biophys; 2018 Jun; 76(1-2):111-124. PubMed ID: 28477056
[TBL] [Abstract][Full Text] [Related]
7. Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes.
He LJ; Zhu YB; Fan QZ; Miao DD; Zhang SP; Liu XP; Zhang C
Bioorg Med Chem Lett; 2019 Feb; 29(4):549-555. PubMed ID: 30630717
[TBL] [Abstract][Full Text] [Related]
8. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase.
Bhojwani HR; Joshi UJ
Curr Comput Aided Drug Des; 2017; 13(3):186-207. PubMed ID: 27981900
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling studies of novel naphthyridine and isoquinoline derivatives as CDK8 inhibitors.
Li Q; Feng K; Liu J; Ren Y
J Biomol Struct Dyn; 2021 Oct; 39(17):6355-6369. PubMed ID: 32723012
[TBL] [Abstract][Full Text] [Related]
11. Structure-based pharmacophore modeling, virtual screening, and molecular dynamics simulation studies for identification of
Oduselu GO; Afolabi R; Ademuwagun I; Vaughan A; Adebiyi E
Front Med (Lausanne); 2022; 9():1022429. PubMed ID: 36714108
[No Abstract] [Full Text] [Related]
12. Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment.
Lin TE; Yang CR; Chou CH; Hsu JY; Chao MW; Sung TY; Hsieh JH; Huang WJ; Hsu KC
Biomed Pharmacother; 2022 Feb; 146():112459. PubMed ID: 34953394
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.
Poonia P; Sharma M; Jha P; Chopra M
Mol Divers; 2023 Oct; 27(5):2053-2071. PubMed ID: 36214962
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors.
Sharma A; Thelma BK
J Mol Model; 2019 Jun; 25(7):179. PubMed ID: 31172362
[TBL] [Abstract][Full Text] [Related]
15. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
[TBL] [Abstract][Full Text] [Related]
17. Computational studies to identify the common type-I and type-II inhibitors against the CDK8 enzyme.
Ghosh A; Manhas A; Jha PC
J Cell Biochem; 2022 Mar; 123(3):628-643. PubMed ID: 34989009
[TBL] [Abstract][Full Text] [Related]
18. Identification of 3, 4-disubstituted pyridine derivatives as novel CDK8 inhibitors.
Zhang H; Jing L; Liu M; Goto M; Lai F; Liu X; Sheng L; Yang Y; Yang Y; Li Y; Chen X; Lee KH; Xiao Z
Eur J Med Chem; 2021 Nov; 223():113634. PubMed ID: 34147745
[TBL] [Abstract][Full Text] [Related]
19. All-Atomic Molecular Dynamic Studies of Human and
Xu W; Xie XJ; Faust AK; Liu M; Li X; Chen F; Naquin AA; Walton AC; Kishbaugh PW; Ji JY
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053834
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore.
Schiemann K; Mallinger A; Wienke D; Esdar C; Poeschke O; Busch M; Rohdich F; Eccles SA; Schneider R; Raynaud FI; Czodrowski P; Musil D; Schwarz D; Urbahns K; Blagg J
Bioorg Med Chem Lett; 2016 Mar; 26(5):1443-51. PubMed ID: 26852363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]